8-K
Current Report
GYRE THERAPEUTICS, INC. Filed Acc 0001193125-20-080653
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading d832615d8k.htm…